In spite of the elevation in the levels of these pro-inflammatory indicators, the levels of HSP10 in the circulation were increased significantly at one day following therapy and were still elevated after 6 months, when the acute phase protein and endothelial dysfunction had returned to baseline, showing that levels of this protein are environmentally controlled. The gene discussed is HSPE1; the disease is endothelial dysfunction.